AQP4 and myeloid sarcoma: The disease is a recently characterized acquired demyelinating syndrome, which has been shown in several reports2,3,4,5 to have clinical and pathological features distinct from multiple sclerosis (MS) and aquaporin-4 antibody–positive neuromyelitis spectrum disorder (AQP4-NMOSD).6,7,8